Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial

被引：66

作者：

Maurer, Marcus ^{[1
]}

Schuetz, Andrea ^{[1
]}

Weller, Karsten ^{[1
]}

Schoepke, Nicole ^{[1
]}

Peveling-Oberhag, Adriane ^{[2
]}

Staubach, Petra ^{[2
]}

Mueller, Sabine ^{[3
]}

Jakob, Thilo ^{[3
,4
]}

Metz, Martin ^{[1
]}

机构：

[1] Charite, Dept Dermatol & Allergy, Berlin, Germany

[2] Univ Med Ctr Mainz, Dept Dermatol, Mainz, Germany

[3] Univ Med Ctr Freiburg, Dept Dermatol, Freiburg, Germany

[4] Justus Liebig Univ, Univ Med Ctr Giessen & Marburg, Dept Dermatol & Allergol, Campus Giessen, Giessen, Germany

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 140卷 / 03期

关键词：

VALIDATION; URTICARIA;

D O I：

10.1016/j.jaci.2017.01.042

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：870 / +

页数：9

共 11 条

[1] Physical Urticarias and Cholinergic Urticaria [J].

Abajian, Marina ;

Schoepke, Nicole ;

Altrichter, Sabine ;

Zuberbier, H. C. Torsten ;

Maurer, Marcus .

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2014, 34 (01) :73-+

[2] The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results [J].

Basra, M. K. A. ;

Fenech, R. ;

Gatt, R. M. ;

Salek, M. S. ;

Finlay, A. Y. .

BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (05) :997-1035

[3] Determining the Minimal Clinically Important Difference and Responsiveness of the Dermatogy Life Quality Index (DLQI): Further Data [J].

Basra, M. K. A. ;

Salek, M. S. ;

Camilleri, L. ;

Sturkey, R. ;

Finlay, A. Y. .

DERMATOLOGY, 2015, 230 (01) :27-33

[4] The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria [J].

Chang, Tse Wen ;

Chen, Christina ;

Lin, Chien-Jen ;

Metz, Martin ;

Church, Martin K. ;

Maurer, Marcus .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) :337-+

[5] Pathomechanisms in physical urticaria [J].

Grabbe, J .

JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2001, 6 (02) :135-136

[6] Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy [J].

Krause, K. ;

Ardelean, E. ;

Kessler, B. ;

Magerl, M. ;

Metz, M. ;

Siebenhaar, F. ;

Weller, K. ;

Worm, M. ;

Zuberbier, T. ;

Maurer, M. .

ALLERGY, 2010, 65 (11) :1494-1495

[7] Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria [J].

Maurer, Marcus ;

Rosen, Karin ;

Hsieh, Hsin-Ju ;

Saini, Sarbjit ;

Grattan, Clive ;

Gimenez-Arnau, Ana ;

Agarwal, Sunil ;

Doyle, Ramona ;

Canvin, Janice ;

Kaplan, Allen ;

Casale, Thomas .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (10) :924-935

[8] Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria [J].

Metz, Martin ;

Altrichter, Sabine ;

Ardelean, Elena ;

Kessler, Birgit ;

Krause, Karoline ;

Magerl, Markus ;

Siebenhaar, Frank ;

Weller, Karsten ;

Zuberbier, Torsten ;

Maurer, Marcus .

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2011, 154 (02) :177-180

[9] Validation of a simplified provocation instrument for diagnosis and threshold testing of symptomatic dermographism [J].

Schoepke, N. ;

Abajian, M. ;

Church, M. K. ;

Magerl, M. .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2015, 40 (04) :399-403

[10] Symptomatic dermographism: an inadequately described disease [J].

Schoepke, N. ;

Mlynek, A. ;

Weller, K. ;

Church, M. K. ;

Maurer, M. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (04) :708-712

← 1 2 →